Emisphere Technologies Inc (EMIS) financial statements (2021 and earlier)

Company profile

Business Address 240 CEDAR KNOLLS RD.
CEDAR KNOLLS, NJ 07927
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments613441
Cash and cash equivalents613441
Receivables00  0
Inventory, net of allowances, customer advances and progress billings01200
Inventory01200
Prepaid expense0000
Deposits current assets 0   
Prepaid expense and other current assets0
Other undisclosed current assets0101 
Total current assets:716652
Noncurrent Assets
Property, plant and equipment 0000
Restricted cash and investments    0
Other noncurrent assets 000
Prepaid expense and other noncurrent assets0
Other undisclosed noncurrent assets0    
Total noncurrent assets:00000
TOTAL ASSETS:716652
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12221
Accounts payable121  
Accrued liabilities001  
Employee-related liabilities000  
Accounts payable and other accrued liabilities10
Other undisclosed accounts payable and accrued liabilities   11
Debt 7 135
Derivative instruments and hedges, liabilities 0011
Deferred revenue and credits11   
Other liabilities   00
Other undisclosed current liabilities813630
Total current liabilities:10238637
Noncurrent Liabilities
Liabilities, other than long-term debt123110864232
Deferred revenue and credits5656424232
Due to related parties685445  
Other undisclosed noncurrent liabilities35352444 
Total noncurrent liabilities:1581451108532
Total liabilities:1681681189268
Stockholders' equity
Stockholders' equity attributable to parent(161)(152)(112)(87)(66)
Common stock11111
Treasury stock, value(4)(4)(4)(4)(4)
Additional paid in capital406406406405405
Accumulated deficit(565)(555)(514)(489)(468)
Total stockholders' equity:(161)(152)(112)(87)(66)
TOTAL LIABILITIES AND EQUITY:716652

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues10  0
Revenue, net    0
Cost of revenue
(Cost of Goods and Services Sold)
(2)(1)   
Gross profit:(0)(0)  0
Operating expenses(8)(18)(10)(9)(7)
Other undisclosed operating income  011
Operating loss:(8)(18)(9)(8)(7)
Nonoperating income (expense)(2)(23)(18)(13)2
Other nonoperating income (expense)  (18)(13)2
Interest and debt expense(0)(9)(6)(5)(6)
Loss from continuing operations before equity method investments, income taxes:(10)(50)(34)(26)(11)
Other undisclosed income from continuing operations before income taxes09656
Loss from continuing operations before income taxes:(10)(41)(27)(21)(5)
Income tax expense (benefit) 12(0)3
Net loss available to common stockholders, diluted:(10)(40)(25)(21)(2)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(10)(40)(25)(21)(2)
Comprehensive loss, net of tax, attributable to parent:(10)(40)(25)(21)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: